Novo Nordisk A/S
NYSE: NVO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Maziar Mike Doustdar
- Employees
- 77,406
- Headquarters
- Bagsvaerd, Denmark
- IPO year
- 1981
- Market cap
- $216.7B
- Website
- https://www.novonordisk.com
Loading NVO…
Loading profile data…Frequently asked questions about NVO
What does Novo Nordisk A/S (NVO) do?
Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America....
Where does NVO trade?
Novo Nordisk A/S (NVO) trades on the New York Stock Exchange.
What sector is NVO in?
Novo Nordisk A/S (NVO) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Novo Nordisk A/S?
Maziar Mike Doustdar is the chief executive officer of Novo Nordisk A/S (NVO).
Where is Novo Nordisk A/S headquartered?
Novo Nordisk A/S is headquartered in Denmark.
When did NVO go public?
Novo Nordisk A/S (NVO) completed its initial public offering in 1981.
Is NVO an ADR?
Yes — NVO is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Novo Nordisk A/S reporting and dividends follow the underlying issuer.